文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Ring Augmentation of the Roux-en-Y Gastric Bypass: A Propensity Score Matched Analysis of 5-Year Follow-Up Results.

作者信息

Jense Marijn T F, Bruinsma Floris F E, Nienhuijs Simon W, Liem Ronald S L, de Mheen Perla J Marang-van, Greve Jan Willem M, Boerma Evert-Jan G

机构信息

Zuyderland Medisch Centrum, Sittard, Netherlands.

Maastricht University, Maastricht, Netherlands.

出版信息

Obes Surg. 2025 Mar;35(3):884-893. doi: 10.1007/s11695-025-07706-x. Epub 2025 Jan 30.


DOI:10.1007/s11695-025-07706-x
PMID:39883395
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11906517/
Abstract

BACKGROUND: The ring-augmented Roux-en-Y gastric bypass (raRYGB) has been reported to result in higher long-term weight loss compared to regular Roux-en-Y gastric bypass (RYGB). However, the type of ring used varied within studies, leading to heterogeneity in reported results. Therefore, this study compares the 5-year results of RYGB with and without ring augmentation using a specific prefabricated gastric ring. METHODS: All consecutive patients from a single center who received primary raRYGB between June 1, 2016, and May 31, 2018, with complete 5-year follow-up data were included and compared to a propensity score matched cohort receiving RYGB in the same period from the Dutch Audit for Treatment of Obesity. To ensure fair effect estimation of placing a ring, only RYGB procedures with alimentary and biliopancreatic limb lengths similar to those of the raRYGB were considered eligible. The primary outcome was percentage total weight loss (%TWL). Secondary outcomes included recurrent weight gain (RWG), obesity complication improvement, and complications. RESULTS: In total, 592 matched patients were analyzed. raRYGB was associated with higher %TWL at 5 years (31.5% versus 28.0%, β = 3.59, 95% CI [2.09-5.09], p < 0.01) and lower odds on RWG (odds ratio = 0.56, 95% CI [0.38-0.83], p < 0.01). Improvement of obesity complications and short-term complication rates were comparable in both groups. After 5 years, 13 patients (4%) had experienced ring-related complications needing reoperation. CONCLUSIONS: At 5 years, raRYGB was associated with higher %TWL and lower odds on RWG. The occurrence of ring-related complications was limited.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2faa/11906517/07d3f91a081e/11695_2025_7706_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2faa/11906517/ec98ce6bead7/11695_2025_7706_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2faa/11906517/07d3f91a081e/11695_2025_7706_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2faa/11906517/ec98ce6bead7/11695_2025_7706_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2faa/11906517/07d3f91a081e/11695_2025_7706_Fig2_HTML.jpg

相似文献

[1]
Ring Augmentation of the Roux-en-Y Gastric Bypass: A Propensity Score Matched Analysis of 5-Year Follow-Up Results.

Obes Surg. 2025-3

[2]
Short-term safety and effectiveness of conversion from sleeve gastrectomy to Ring augmented Roux-en-Y gastric bypass.

BMC Surg. 2024-9-19

[3]
Five-year outcomes of a randomized controlled trial evaluating a non-adjustable ring in Roux-en-Y gastric bypass.

Surg Endosc. 2025-4

[4]
Primary Roux-en-Y Gastric Bypass Results in Greater Weight Loss at 15-Year Follow-Up Compared with Secondary Roux-en-Y Gastric Bypass After Failure of Gastric Band or Mason McLean Vertical Gastroplasty.

Obes Surg. 2020-10

[5]
Banded Roux-en-Y gastric bypass in patients with super morbid obesity (BRandY-study): protocol of a cohort study with 10 year follow-up.

BMC Surg. 2020-6-5

[6]
Comparable results 5 years after one anastomosis gastric bypass compared to Roux-en-Y gastric bypass: a propensity-score matched analysis.

Surg Obes Relat Dis. 2025-3

[7]
The One Anastomosis Gastric Bypass Is a Suitable Alternative to Roux-en-Y Gastric Bypass in Patients with Body Mass Index ≥50 kg/m2: A Propensity Score-Matched Analysis.

Obes Facts. 2025

[8]
Enhanced Total Weight Loss 2 Years Post-Roux-en-Y Gastric Bypass with Longer Biliopancreatic Limb.

Obes Surg. 2025-4

[9]
Long-term weight loss outcomes after banded Roux-en-Y gastric bypass: a prospective 10-year follow-up study.

Surg Obes Relat Dis. 2018-3-26

[10]
[Comparison of 1-year outcomes between Roux-en-Y gastric bypass and sleeve gastrectomy with Roux-en-Y duodenojejunal bypass in the patients of obesity with type 2 diabetes mellitus].

Zhonghua Wei Chang Wai Ke Za Zhi. 2023-11-25

引用本文的文献

[1]
A Ring-Augmented Roux-en-Y Gastric Bypass with MiniMizer Ring is Effective and Safe in Patients with a BMI >50 kg/m.

Obes Surg. 2025-6-26

本文引用的文献

[1]
The Impact of Longer Biliopancreatic Limb Length on Weight Loss and Comorbidity Improvement at 5 Years After Primary Roux-en-Y Gastric Bypass Surgery: A Population-Based Matched Cohort Study.

Obes Surg. 2024-9

[2]
Clarifying Terminology in Bariatric Metabolic Surgery: The Need for Distinction Between "Band" and "Ring".

Obes Surg. 2024-5

[3]
IFSO Consensus on Definitions and Clinical Practice Guidelines for Obesity Management-an International Delphi Study.

Obes Surg. 2024-1

[4]
Efficacy and safety of revisional treatments for weight regain or insufficient weight loss after Roux-en-Y gastric bypass: A systematic review and meta-analysis.

Obes Rev. 2023-10

[5]
Treatment with Antiobesity Drugs in Weight Regain After Bariatric Surgery: a Retrospective Cohort Study.

Obes Surg. 2023-9

[6]
Weight loss maintenance after bariatric surgery.

World J Clin Cases. 2023-6-26

[7]
Combination anti-obesity medications to effectively treat bariatric surgery weight regain at an academic obesity center.

Obes Sci Pract. 2022-9-24

[8]
Weight Regain After Bariatric Surgery: Scope of the Problem, Causes, Prevention, and Treatment.

Curr Diab Rep. 2023-3

[9]
Weight recurrence after Sleeve Gastrectomy versus Roux-en-Y gastric bypass: a propensity score matched nationwide analysis.

Surg Endosc. 2023-6

[10]
Pharmacologic management of weight regain following bariatric surgery.

Front Endocrinol (Lausanne). 2022

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索